A parasite biomarker set for evaluating benznidazole treatment efficacy in patients with chronic asymptomatic Trypanosoma cruzi infection.

This work was financially supported by grants SAF2016-81003-R, SAF2016-80998-R, and RTC-2014-2130 from the Programa Estatal I + D + i (MINECO); the Network of Tropical Diseases Research RICET (RD16/0027/0005 and RD16/0027/0016); and FEDER. This publication is part of the PhD thesis of the student Elena Perez-Anton at the University of Granada in the Biomedicine Program.